Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery
NCT06776042 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2026-04-27
Summary
The goal of this clinical trial is to understand the mechanisms leading to olfactory dysfunction (OD) in chronic rhinosinusitis (CRS). The main questions it aims to answer are:
* Is the type 2 inflammation impacting the olfactory epithelium regeneration, leading to OD?
* Does a treatment interfering with one of the major T2 inflammatory cytokines, have an impact on the mechanisms of OD in CRS?
Participants will undergo olfactory testing and nasal brushing before and after 3 months of treatment.
Conditions
- Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions
- OTHER
-
Nasal brushing of the olfactory cleft
Nasal brushing of the olfactory cleft
- OTHER
-
Smell testing
Smell testing using the Sniffin' Sticks Test
Sponsors & Collaborators
-
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
lead OTHER
Principal Investigators
-
Valérie Hox, MD, PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-22
- Primary Completion
- 2026-09-30
- Completion
- 2026-09-30
Countries
- Belgium
Study Locations
More Related Trials
-
The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device
NCT02079792 ·Status: COMPLETED ·Phase: PHASE4
-
Nasal Obstruction and Olfactory Losses
NCT05920330 ·Status: RECRUITING ·Phase: NA
-
Blown Nasal Secretion Measurements in Rhinosinusitis: Repeatability and Validity Compared to Nasal Lavage
NCT00292851 ·Status: COMPLETED
-
Mechanisms of Smell Improvement With Dupilumab.
NCT05964465 ·Status: COMPLETED ·Phase: PHASE4
-
Olfactory Training in Chronic Rhinosinusitis
NCT03055572 ·Status: WITHDRAWN ·Phase: NA
-
Olfactory Dysfunction of Rhinosinusitis
NCT00797004 ·Status: COMPLETED
-
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
NCT06076304 ·Status: RECRUITING ·Phase: PHASE4
-
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
NCT01814618 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evolution of the Endonasal Microbiota in Patients With Chronic Rhinosinusitis
NCT04418622 ·Status: COMPLETED
-
Evaluation of Inhaled Treatment in Sinusitis
NCT01907204 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
NCT03478930 ·Status: COMPLETED ·Phase: PHASE3
-
Olfaction and Inflammation in Chronic Rhinosinusitis With Nasal Polyps
NCT04104594 ·Status: TERMINATED ·Phase: NA
-
Olfactory Dysfunction of Rhinosinusitis - Cyclic Adenosine Monophosphate (cAMP)/Calcium Signaling Study
NCT00970190 ·Status: COMPLETED
-
Impact of Structural and Microenvironmental Abnormalities in Olfactory Cleft on Olfaction in CRS
NCT06834477 ·Status: NOT_YET_RECRUITING
-
The Long-Term Safety of Budesonide for Patients With Chronic Rhinosinusitis
NCT03584178 ·Status: UNKNOWN ·Phase: NA
-
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
NCT04998604 ·Status: COMPLETED ·Phase: PHASE4
-
Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation
NCT06482138 ·Status: RECRUITING ·Phase: NA
-
Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
NCT06683261 ·Status: RECRUITING
-
Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates
NCT03519061 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
NCT03781804 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-Inflammatory Agent in Sinusitis
NCT02874144 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
NCT05855369 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Eosinophils Endotypes in Chronic Airway Inflammatory Diseases
NCT04187976 ·Status: COMPLETED
-
Endoscopic Sinus Surgery for Refractory Chronic Sinusitis
NCT02506426 ·Status: UNKNOWN ·Phase: NA
-
Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps
NCT01732536 ·Status: COMPLETED ·Phase: PHASE2/PHASE3